Global Biobanking For Medicine Market

Biobanking For Medicine Comprehensive Study by Application (Regenerative Medicine, Life Science Research, Clinical Research), Product and Service (Equipment, Consumables, Services, Software), Sample Type (Blood Products, Human Tissues, Nucleic Acids, Cell Lines, Biological Fluids, Human Waste Products), Biobank (Population-based Biobanks, Disease- Oriented Biobanks), Storage Type (Manual Storage, Automated Storage) Players and Region - Global Market Outlook to 2027

Biobanking For Medicine Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 8.2%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Biobanking For Medicine
Due to advancements in regenerative medicine, the rising incidence of chronic diseases, advances in drug discovery and development, and R&D funding and investments by government and non-governmental organizations, the global Biobanking For Medicine market is expected to see high demand during the forecasted period. Biospecimens and associated data are collected, processed, stored, and distributed by the TA biobank for use in fundamental, translational, and clinical research. As the world's population ages, long-term storage of healthy tissue is becoming more popular. Healthy tissue, such as embryonic stem cells from cord blood, can be biobank and used to rebuild damaged tissue. Furthermore, the emergence of COVID-19 has positioned biobanks at the forefront of pandemic preparedness efforts, leading in market organic revenue growth.

AttributesDetails
Study Period2017-2027
Base Year2021
High Growth MarketAsia Pacific
UnitValue (USD Million)
CAGR8.2%


Due to the presence of significant competitors in the industry, the global Biobanking For Medicine market appears to be highly competitive. To keep ahead of the competition and increase their worldwide reach, the top players use mergers & acquisitions and product innovation as a crucial strategy. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Biobanking For Medicine market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Thermo Fisher Scientific Inc. (United States), Tecan Group Ltd. (Switzerland), Qiagen N.V. (Germany), Hamilton Company (United States), Becton, Dickinson and Company (United States), Merck KGaA (Germany), Brooks Automation (United States), TTP Labtech Ltd (United Kingdom), VWR Corporation (United States), Promega Corporation (United States), Worthington Industries (United States) and Chart Industries (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Micronic (Netherlands), LVL Technologies GmbH & Co. KG (Germany), Panasonic Healthcare Holdings Co. Ltd (Japan), Greiner Bio One (Austria), Biokryo GmbH (Germany), Biobank AS (Norway), Biorep Technologies Inc. (United States), Cell & Co Bioservices (France), RUCDR infinite biologics (United States), Modul-Bio (France), CSols Ltd (United Kingdom), Ziath (United Kingdom) and LabVantage Solutions Inc.(United States).

Segmentation Overview
AMA Research has segmented the market of Global Biobanking For Medicine market by , Application (Regenerative Medicine, Life Science Research and Clinical Research) and Region.



On the basis of geography, the market of Biobanking For Medicine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2021. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Product and Service, the sub-segment i.e. Equipment will boost the Biobanking For Medicine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Sample Type, the sub-segment i.e. Blood Products will boost the Biobanking For Medicine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Biobank, the sub-segment i.e. Population-based Biobanks will boost the Biobanking For Medicine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Storage Type, the sub-segment i.e. Manual Storage will boost the Biobanking For Medicine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
On 24th February 2021, QIAGEN and INOVIO Pharmaceuticals has announced an extension of their partnership with a new master collaboration agreement to develop liquid biopsy-based companion* diagnostic products based on next-generation sequencing (NGS) technology to complement INOVIO’s therapies.
On 14th September 2020, Thermo Fisher Scientific, the world leader in serving science, today announced new collaborations of the Thermo Fisher Precision Medicine Science Center (PMSC) with AstraZeneca and the University of Nebraska Medical Center as part of its ongoing development of innovative solutions for unmet needs in clinical biomarker discovery.
HIPAA and HITECH, Both the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the Health Information Technology for Economic and Clinical Health Act (HITECH) regulate how companies in the U.S. collect, store, use and disclose any individually identifiable health information, such as electronic health records. Biobanks must encrypt all Protected Health Information and securely store this information in HIPAA and HITECH-compliant data centers, such as biobank management software., 21 CFR Part 11 and CFR stands for Code of Federal Regulations. 21 CFR Part 11 regulates the authenticity and confidentiality of electronic records and electronic signatures used by biobanks, and other life science organizations, in the U.S. Requirements include system validations, operational systems checks, limited user access, authority checks and regular audits with complete audit trails. Compliant biobank management software can help companies abide by 21 CFR Part 11.

Market Drivers
  • Increased Genomic Research Activities for Disease Studying have resulted in a high rate of adoption.
  • Advances in Biobanking and the Growing Trend of Preserving Newborn Cord Blood Stem Cells

Opportunities
  • High Demand for Emerging Countries
  • Increasing Focus on the R&D of Cell Therapies

Restraints
  • The Growing Concern of High Cost of Automation
  • Increasing Issues Related to Biospecimen Sample Procurement

Challenges
  • Long-Term Sustainability of Biobanks


Key Target Audience
Biobanking associations, Research & consulting firms, Distributors of research products, Contract manufacturers of biobanking equipment and consumables, Research institutes and clinical research organizations (CROs), Venture capitalists and Government associations

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Application
  • Regenerative Medicine
  • Life Science Research
  • Clinical Research
By Product and Service
  • Equipment
  • Consumables
  • Services
  • Software

By Sample Type
  • Blood Products
  • Human Tissues
  • Nucleic Acids
  • Cell Lines
  • Biological Fluids
  • Human Waste Products

By Biobank
  • Population-based Biobanks
  • Disease- Oriented Biobanks

By Storage Type
  • Manual Storage
  • Automated Storage

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Genomic Research Activities for Disease Studying have resulted in a high rate of adoption.
      • 3.2.2. Advances in Biobanking and the Growing Trend of Preserving Newborn Cord Blood Stem Cells
    • 3.3. Market Challenges
      • 3.3.1. Long-Term Sustainability of Biobanks
    • 3.4. Market Trends
      • 3.4.1. High Adoption due to Government and Private Funding to Support Regenerative Medicine Research
      • 3.4.2. Upsurging Requirements for Cost-Effective Drug Discovery as well as Development
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biobanking For Medicine, by Application, Product and Service, Sample Type, Biobank, Storage Type and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Biobanking For Medicine (Value)
      • 5.2.1. Global Biobanking For Medicine by: Application (Value)
        • 5.2.1.1. Regenerative Medicine
        • 5.2.1.2. Life Science Research
        • 5.2.1.3. Clinical Research
      • 5.2.2. Global Biobanking For Medicine by: Product and Service (Value)
        • 5.2.2.1. Equipment
        • 5.2.2.2. Consumables
        • 5.2.2.3. Services
        • 5.2.2.4. Software
      • 5.2.3. Global Biobanking For Medicine by: Sample Type (Value)
        • 5.2.3.1. Blood Products
        • 5.2.3.2. Human Tissues
        • 5.2.3.3. Nucleic Acids
        • 5.2.3.4. Cell Lines
        • 5.2.3.5. Biological Fluids
        • 5.2.3.6. Human Waste Products
      • 5.2.4. Global Biobanking For Medicine by: Biobank (Value)
        • 5.2.4.1. Population-based Biobanks
        • 5.2.4.2. Disease- Oriented Biobanks
      • 5.2.5. Global Biobanking For Medicine by: Storage Type (Value)
        • 5.2.5.1. Manual Storage
        • 5.2.5.2. Automated Storage
      • 5.2.6. Global Biobanking For Medicine Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Biobanking For Medicine (Price)
  • 6. Biobanking For Medicine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Tecan Group Ltd. (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Qiagen N.V. (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Hamilton Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Becton, Dickinson and Company (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck KGaA (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Brooks Automation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. TTP Labtech Ltd (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. VWR Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Promega Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Worthington Industries (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Chart Industries (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Biobanking For Medicine Sale, by Application, Product and Service, Sample Type, Biobank, Storage Type and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Biobanking For Medicine (Value)
      • 7.2.1. Global Biobanking For Medicine by: Application (Value)
        • 7.2.1.1. Regenerative Medicine
        • 7.2.1.2. Life Science Research
        • 7.2.1.3. Clinical Research
      • 7.2.2. Global Biobanking For Medicine by: Product and Service (Value)
        • 7.2.2.1. Equipment
        • 7.2.2.2. Consumables
        • 7.2.2.3. Services
        • 7.2.2.4. Software
      • 7.2.3. Global Biobanking For Medicine by: Sample Type (Value)
        • 7.2.3.1. Blood Products
        • 7.2.3.2. Human Tissues
        • 7.2.3.3. Nucleic Acids
        • 7.2.3.4. Cell Lines
        • 7.2.3.5. Biological Fluids
        • 7.2.3.6. Human Waste Products
      • 7.2.4. Global Biobanking For Medicine by: Biobank (Value)
        • 7.2.4.1. Population-based Biobanks
        • 7.2.4.2. Disease- Oriented Biobanks
      • 7.2.5. Global Biobanking For Medicine by: Storage Type (Value)
        • 7.2.5.1. Manual Storage
        • 7.2.5.2. Automated Storage
      • 7.2.6. Global Biobanking For Medicine Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Biobanking For Medicine (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biobanking For Medicine: by Application(USD Million)
  • Table 2. Biobanking For Medicine Regenerative Medicine , by Region USD Million (2016-2021)
  • Table 3. Biobanking For Medicine Life Science Research , by Region USD Million (2016-2021)
  • Table 4. Biobanking For Medicine Clinical Research , by Region USD Million (2016-2021)
  • Table 5. Biobanking For Medicine: by Product and Service(USD Million)
  • Table 6. Biobanking For Medicine Equipment , by Region USD Million (2016-2021)
  • Table 7. Biobanking For Medicine Consumables , by Region USD Million (2016-2021)
  • Table 8. Biobanking For Medicine Services , by Region USD Million (2016-2021)
  • Table 9. Biobanking For Medicine Software , by Region USD Million (2016-2021)
  • Table 10. Biobanking For Medicine: by Sample Type(USD Million)
  • Table 11. Biobanking For Medicine Blood Products , by Region USD Million (2016-2021)
  • Table 12. Biobanking For Medicine Human Tissues , by Region USD Million (2016-2021)
  • Table 13. Biobanking For Medicine Nucleic Acids , by Region USD Million (2016-2021)
  • Table 14. Biobanking For Medicine Cell Lines , by Region USD Million (2016-2021)
  • Table 15. Biobanking For Medicine Biological Fluids , by Region USD Million (2016-2021)
  • Table 16. Biobanking For Medicine Human Waste Products , by Region USD Million (2016-2021)
  • Table 17. Biobanking For Medicine: by Biobank(USD Million)
  • Table 18. Biobanking For Medicine Population-based Biobanks , by Region USD Million (2016-2021)
  • Table 19. Biobanking For Medicine Disease- Oriented Biobanks , by Region USD Million (2016-2021)
  • Table 20. Biobanking For Medicine: by Storage Type(USD Million)
  • Table 21. Biobanking For Medicine Manual Storage , by Region USD Million (2016-2021)
  • Table 22. Biobanking For Medicine Automated Storage , by Region USD Million (2016-2021)
  • Table 23. South America Biobanking For Medicine, by Country USD Million (2016-2021)
  • Table 24. South America Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 25. South America Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 26. South America Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 27. South America Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 28. South America Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 29. Brazil Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 30. Brazil Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 31. Brazil Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 32. Brazil Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 33. Brazil Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 34. Argentina Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 35. Argentina Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 36. Argentina Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 37. Argentina Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 38. Argentina Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 39. Rest of South America Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 40. Rest of South America Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 41. Rest of South America Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 42. Rest of South America Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 43. Rest of South America Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 44. Asia Pacific Biobanking For Medicine, by Country USD Million (2016-2021)
  • Table 45. Asia Pacific Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 46. Asia Pacific Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 47. Asia Pacific Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 48. Asia Pacific Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 49. Asia Pacific Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 50. China Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 51. China Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 52. China Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 53. China Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 54. China Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 55. Japan Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 56. Japan Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 57. Japan Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 58. Japan Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 59. Japan Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 60. India Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 61. India Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 62. India Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 63. India Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 64. India Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 65. South Korea Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 66. South Korea Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 67. South Korea Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 68. South Korea Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 69. South Korea Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 70. Taiwan Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 71. Taiwan Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 72. Taiwan Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 73. Taiwan Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 74. Taiwan Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 75. Australia Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 76. Australia Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 77. Australia Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 78. Australia Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 79. Australia Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 80. Rest of Asia-Pacific Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 81. Rest of Asia-Pacific Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 82. Rest of Asia-Pacific Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 83. Rest of Asia-Pacific Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 84. Rest of Asia-Pacific Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 85. Europe Biobanking For Medicine, by Country USD Million (2016-2021)
  • Table 86. Europe Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 87. Europe Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 88. Europe Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 89. Europe Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 90. Europe Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 91. Germany Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 92. Germany Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 93. Germany Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 94. Germany Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 95. Germany Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 96. France Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 97. France Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 98. France Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 99. France Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 100. France Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 101. Italy Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 102. Italy Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 103. Italy Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 104. Italy Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 105. Italy Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 106. United Kingdom Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 107. United Kingdom Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 108. United Kingdom Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 109. United Kingdom Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 110. United Kingdom Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 111. Netherlands Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 112. Netherlands Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 113. Netherlands Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 114. Netherlands Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 115. Netherlands Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 116. Rest of Europe Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 117. Rest of Europe Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 118. Rest of Europe Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 119. Rest of Europe Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 120. Rest of Europe Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 121. MEA Biobanking For Medicine, by Country USD Million (2016-2021)
  • Table 122. MEA Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 123. MEA Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 124. MEA Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 125. MEA Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 126. MEA Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 127. Middle East Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 128. Middle East Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 129. Middle East Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 130. Middle East Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 131. Middle East Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 132. Africa Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 133. Africa Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 134. Africa Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 135. Africa Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 136. Africa Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 137. North America Biobanking For Medicine, by Country USD Million (2016-2021)
  • Table 138. North America Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 139. North America Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 140. North America Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 141. North America Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 142. North America Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 143. United States Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 144. United States Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 145. United States Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 146. United States Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 147. United States Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 148. Canada Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 149. Canada Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 150. Canada Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 151. Canada Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 152. Canada Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 153. Mexico Biobanking For Medicine, by Application USD Million (2016-2021)
  • Table 154. Mexico Biobanking For Medicine, by Product and Service USD Million (2016-2021)
  • Table 155. Mexico Biobanking For Medicine, by Sample Type USD Million (2016-2021)
  • Table 156. Mexico Biobanking For Medicine, by Biobank USD Million (2016-2021)
  • Table 157. Mexico Biobanking For Medicine, by Storage Type USD Million (2016-2021)
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Biobanking For Medicine: by Application(USD Million)
  • Table 171. Biobanking For Medicine Regenerative Medicine , by Region USD Million (2022-2027)
  • Table 172. Biobanking For Medicine Life Science Research , by Region USD Million (2022-2027)
  • Table 173. Biobanking For Medicine Clinical Research , by Region USD Million (2022-2027)
  • Table 174. Biobanking For Medicine: by Product and Service(USD Million)
  • Table 175. Biobanking For Medicine Equipment , by Region USD Million (2022-2027)
  • Table 176. Biobanking For Medicine Consumables , by Region USD Million (2022-2027)
  • Table 177. Biobanking For Medicine Services , by Region USD Million (2022-2027)
  • Table 178. Biobanking For Medicine Software , by Region USD Million (2022-2027)
  • Table 179. Biobanking For Medicine: by Sample Type(USD Million)
  • Table 180. Biobanking For Medicine Blood Products , by Region USD Million (2022-2027)
  • Table 181. Biobanking For Medicine Human Tissues , by Region USD Million (2022-2027)
  • Table 182. Biobanking For Medicine Nucleic Acids , by Region USD Million (2022-2027)
  • Table 183. Biobanking For Medicine Cell Lines , by Region USD Million (2022-2027)
  • Table 184. Biobanking For Medicine Biological Fluids , by Region USD Million (2022-2027)
  • Table 185. Biobanking For Medicine Human Waste Products , by Region USD Million (2022-2027)
  • Table 186. Biobanking For Medicine: by Biobank(USD Million)
  • Table 187. Biobanking For Medicine Population-based Biobanks , by Region USD Million (2022-2027)
  • Table 188. Biobanking For Medicine Disease- Oriented Biobanks , by Region USD Million (2022-2027)
  • Table 189. Biobanking For Medicine: by Storage Type(USD Million)
  • Table 190. Biobanking For Medicine Manual Storage , by Region USD Million (2022-2027)
  • Table 191. Biobanking For Medicine Automated Storage , by Region USD Million (2022-2027)
  • Table 192. South America Biobanking For Medicine, by Country USD Million (2022-2027)
  • Table 193. South America Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 194. South America Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 195. South America Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 196. South America Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 197. South America Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 198. Brazil Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 199. Brazil Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 200. Brazil Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 201. Brazil Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 202. Brazil Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 203. Argentina Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 204. Argentina Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 205. Argentina Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 206. Argentina Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 207. Argentina Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 208. Rest of South America Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 209. Rest of South America Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 210. Rest of South America Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 211. Rest of South America Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 212. Rest of South America Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 213. Asia Pacific Biobanking For Medicine, by Country USD Million (2022-2027)
  • Table 214. Asia Pacific Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 215. Asia Pacific Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 216. Asia Pacific Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 217. Asia Pacific Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 218. Asia Pacific Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 219. China Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 220. China Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 221. China Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 222. China Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 223. China Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 224. Japan Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 225. Japan Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 226. Japan Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 227. Japan Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 228. Japan Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 229. India Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 230. India Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 231. India Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 232. India Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 233. India Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 234. South Korea Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 235. South Korea Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 236. South Korea Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 237. South Korea Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 238. South Korea Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 239. Taiwan Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 240. Taiwan Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 241. Taiwan Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 242. Taiwan Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 243. Taiwan Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 244. Australia Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 245. Australia Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 246. Australia Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 247. Australia Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 248. Australia Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 249. Rest of Asia-Pacific Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 250. Rest of Asia-Pacific Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 251. Rest of Asia-Pacific Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 252. Rest of Asia-Pacific Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 253. Rest of Asia-Pacific Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 254. Europe Biobanking For Medicine, by Country USD Million (2022-2027)
  • Table 255. Europe Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 256. Europe Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 257. Europe Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 258. Europe Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 259. Europe Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 260. Germany Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 261. Germany Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 262. Germany Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 263. Germany Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 264. Germany Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 265. France Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 266. France Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 267. France Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 268. France Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 269. France Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 270. Italy Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 271. Italy Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 272. Italy Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 273. Italy Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 274. Italy Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 275. United Kingdom Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 276. United Kingdom Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 277. United Kingdom Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 278. United Kingdom Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 279. United Kingdom Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 280. Netherlands Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 281. Netherlands Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 282. Netherlands Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 283. Netherlands Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 284. Netherlands Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 285. Rest of Europe Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 286. Rest of Europe Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 287. Rest of Europe Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 288. Rest of Europe Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 289. Rest of Europe Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 290. MEA Biobanking For Medicine, by Country USD Million (2022-2027)
  • Table 291. MEA Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 292. MEA Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 293. MEA Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 294. MEA Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 295. MEA Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 296. Middle East Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 297. Middle East Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 298. Middle East Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 299. Middle East Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 300. Middle East Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 301. Africa Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 302. Africa Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 303. Africa Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 304. Africa Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 305. Africa Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 306. North America Biobanking For Medicine, by Country USD Million (2022-2027)
  • Table 307. North America Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 308. North America Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 309. North America Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 310. North America Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 311. North America Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 312. United States Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 313. United States Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 314. United States Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 315. United States Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 316. United States Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 317. Canada Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 318. Canada Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 319. Canada Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 320. Canada Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 321. Canada Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 322. Mexico Biobanking For Medicine, by Application USD Million (2022-2027)
  • Table 323. Mexico Biobanking For Medicine, by Product and Service USD Million (2022-2027)
  • Table 324. Mexico Biobanking For Medicine, by Sample Type USD Million (2022-2027)
  • Table 325. Mexico Biobanking For Medicine, by Biobank USD Million (2022-2027)
  • Table 326. Mexico Biobanking For Medicine, by Storage Type USD Million (2022-2027)
  • Table 327. Research Programs/Design for This Report
  • Table 328. Key Data Information from Secondary Sources
  • Table 329. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biobanking For Medicine: by Application USD Million (2016-2021)
  • Figure 5. Global Biobanking For Medicine: by Product and Service USD Million (2016-2021)
  • Figure 6. Global Biobanking For Medicine: by Sample Type USD Million (2016-2021)
  • Figure 7. Global Biobanking For Medicine: by Biobank USD Million (2016-2021)
  • Figure 8. Global Biobanking For Medicine: by Storage Type USD Million (2016-2021)
  • Figure 9. South America Biobanking For Medicine Share (%), by Country
  • Figure 10. Asia Pacific Biobanking For Medicine Share (%), by Country
  • Figure 11. Europe Biobanking For Medicine Share (%), by Country
  • Figure 12. MEA Biobanking For Medicine Share (%), by Country
  • Figure 13. North America Biobanking For Medicine Share (%), by Country
  • Figure 14. Global Biobanking For Medicine share by Players 2021 (%)
  • Figure 15. Global Biobanking For Medicine share by Players (Top 3) 2021(%)
  • Figure 16. Global Biobanking For Medicine share by Players (Top 5) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2021
  • Figure 20. Tecan Group Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 21. Tecan Group Ltd. (Switzerland) Revenue: by Geography 2021
  • Figure 22. Qiagen N.V. (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Qiagen N.V. (Germany) Revenue: by Geography 2021
  • Figure 24. Hamilton Company (United States) Revenue, Net Income and Gross profit
  • Figure 25. Hamilton Company (United States) Revenue: by Geography 2021
  • Figure 26. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 27. Becton, Dickinson and Company (United States) Revenue: by Geography 2021
  • Figure 28. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Merck KGaA (Germany) Revenue: by Geography 2021
  • Figure 30. Brooks Automation (United States) Revenue, Net Income and Gross profit
  • Figure 31. Brooks Automation (United States) Revenue: by Geography 2021
  • Figure 32. TTP Labtech Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 33. TTP Labtech Ltd (United Kingdom) Revenue: by Geography 2021
  • Figure 34. VWR Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 35. VWR Corporation (United States) Revenue: by Geography 2021
  • Figure 36. Promega Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 37. Promega Corporation (United States) Revenue: by Geography 2021
  • Figure 38. Worthington Industries (United States) Revenue, Net Income and Gross profit
  • Figure 39. Worthington Industries (United States) Revenue: by Geography 2021
  • Figure 40. Chart Industries (United States) Revenue, Net Income and Gross profit
  • Figure 41. Chart Industries (United States) Revenue: by Geography 2021
  • Figure 42. Global Biobanking For Medicine: by Application USD Million (2022-2027)
  • Figure 43. Global Biobanking For Medicine: by Product and Service USD Million (2022-2027)
  • Figure 44. Global Biobanking For Medicine: by Sample Type USD Million (2022-2027)
  • Figure 45. Global Biobanking For Medicine: by Biobank USD Million (2022-2027)
  • Figure 46. Global Biobanking For Medicine: by Storage Type USD Million (2022-2027)
  • Figure 47. South America Biobanking For Medicine Share (%), by Country
  • Figure 48. Asia Pacific Biobanking For Medicine Share (%), by Country
  • Figure 49. Europe Biobanking For Medicine Share (%), by Country
  • Figure 50. MEA Biobanking For Medicine Share (%), by Country
  • Figure 51. North America Biobanking For Medicine Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific Inc. (United States)
  • Tecan Group Ltd. (Switzerland)
  • Qiagen N.V. (Germany)
  • Hamilton Company (United States)
  • Becton, Dickinson and Company (United States)
  • Merck KGaA (Germany)
  • Brooks Automation (United States)
  • TTP Labtech Ltd (United Kingdom)
  • VWR Corporation (United States)
  • Promega Corporation (United States)
  • Worthington Industries (United States)
  • Chart Industries (United States)
Additional players considered in the study are as follows:
Micronic (Netherlands) , LVL Technologies GmbH & Co. KG (Germany) , Panasonic Healthcare Holdings Co. Ltd (Japan) , Greiner Bio One (Austria) , Biokryo GmbH (Germany) , Biobank AS (Norway) , Biorep Technologies Inc. (United States) , Cell & Co Bioservices (France) , RUCDR infinite biologics (United States) , Modul-Bio (France), CSols Ltd (United Kingdom) , Ziath (United Kingdom) , LabVantage Solutions Inc.(United States)
Select User Access Type

Key Highlights of Report


Jul 2022 166 Pages 66 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Biobanking For Medicine Market Quantitative research analysis
Global Biobanking For Medicine Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Thermo Fisher Scientific Inc. (United States), Tecan Group Ltd. (Switzerland), Qiagen N.V. (Germany), Hamilton Company (United States), Becton, Dickinson and Company (United States), Merck KGaA (Germany), Brooks Automation (United States), TTP Labtech Ltd (United Kingdom), VWR Corporation (United States), Promega Corporation (United States), Worthington Industries (United States) and Chart Industries (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"High Adoption due to Government and Private Funding to Support Regenerative Medicine Research " is seen as one of major influencing trends for Biobanking For Medicine Market during projected period 2021-2027.
The Biobanking For Medicine market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.
Analysts at AMA estimates Biobanking For Medicine Market to reach USD58518.7 Million by 2027.

Know More About Global Biobanking For Medicine Market Report?

Have a Query? Click Here

Other Related Reports

3-D Mammography Comprehensive Study by Type (Screening, Diagnostics), Application (Diagnostic Purpose, Treatments of Cancer), End-User (Hospitals, Surgical Clinics, & Diagnostic Imaging Centers, Brea...
$ 3750
Telemedicine Monitoring Systems Comprehensive Study by Type (COPD Telemedicine Monitoring Systems, Glucose Level Telemedicine Monitoring Systems, Blood Pressure Telemedicine Monitoring Systems, Cardi...
$ 3750
AI in Medication Management Comprehensive Study by Type (Hardware, Software, Services), Application (Patient data and Risk analysis, Inpatient care & Hospital Management, Medical Imaging and Diagnost...
$ 3750
Disinfection Robots Comprehensive Study by Type (UV-Disinfection Robot, Hydrogen Peroxide Vaporization Robot), End-User (Hospitals, Research Institutes, Others) Players and Region - Global Market Out...
$ 3500
Electronic Drug Delivery Systems Comprehensive Study by Type (Wearable Infusion Pumps, Autoinjectors, Injection Pens, Inhalers, Others), Application (Cardiovascular Disease, Diabetes, Multiple Sclero...
$ 3750
Radiotherapy Motion Management Comprehensive Study by Type (Spirometric Motion Management, Intrafraction Radiotherapy Motion Management, Others), Application (Hospitals, Radiation Therapy Centers, Am...
$ 3350